Clinical trial
Molecular Targeted Maintenance Therapy Versus Standard of Care in Advanced Biliary Cancer: an International, Randomised, Controlled, Open-label, Platform Phase 3 Trial
NCT05615818 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Molecular Targeted Maintenance Therapy Versus Standard of Care in Advanced Biliary Cancer: an International, Randomised, Controlled, Open-label, Platform Phase 3 Trial
- Lead sponsor
- UNICANCER
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- July 18, 2024
- Completion date
- June 30, 2028
- Enrollment
- 800 (estimated)
- Sites
- 69
Conditions
As the registry lists them; a condition with its own page is linked.